Event
26th Sidley China Life Sciences Roundtable
Wednesday, June 4, 2025 – Friday, June 6, 2025
イベント詳細
日付Wednesday, June 4, 2025 – Friday, June 6, 2025
Beijing | Wednesday, June 4, 2025
The Ritz-Carlton, Beijing
Ballroom 1 (B1 Floor)
8:30 a.m. CST (check-in)
9:00 a.m. – 12:30 p.m. CST
Lunch to follow
Shanghai | Friday, June 6, 2025
The Ritz-Carlton Shanghai, Pudong
Amber Room (Level 3)
8:30 a.m. CST (check-in)
9:00 a.m. – 12:30 p.m. CST
Lunch to follow
RSVP here.
This half-day benchmarking event provides an intimate setting for lawyers and compliance officers to engage in an interactive dialogue on the following topics:
- From 2015 to 2025: A 10-year Overview of China’s Life Sciences Regulations — What’s Happened and What’s Next
- What “Sanctions” Mean: International Trade Compliance for Pharmaceutical and Medical Device Companies
- U.S. Outbound Investment Rules and America First Investment Policy: Impacts on Chinese Biotechs
- An introduction to the U.S. FDA Guidance for Use of AI in Drug Developments
- Compliance Essentials for Life Sciences Companies in Hong Kong
Speakers
- Chen Yang, Senior Counsel, Sidley
- Lei Li, Partner, Sidley
- Ruchun Ji, Partner, Sidley
- Shu Min Ho, Partner, Sidley
Should you have any questions, please contact sidleychinalifesciencesroundtable@sidley.com.
連絡先
Offices
関連リソース
関連ブログ
得意分野
Suggested News & Insights
A New World Order – Market Access, MFN, and GeopoliticsTuesday, November 10, 2026Sidley & Trinity Capital Life Sciences ReceptionThursday, October 22, 2026Sidley Represents Telix Pharmaceuticals in Its US$1.65 Billion Merger With ITMOctober 5, 2026Most-Favored-Nation Drug Pricing for Medicare Part B Significantly Narrowed in Final RuleOctober 5, 2026Sidley Represents Jiangsu Hengrui in Connection With US$2.6 Billion Licensing Agreement With Novo NordiskOctober 1, 2026Sidley Represents Pyxis Oncology in an up to US$282.6 Million Public OfferingOctober 1, 2026
- Stay Up To DateSubscribe to Sidley Publications
- Follow Sidley on Social MediaSocial Media Directory